Public Employees Retirement System of Ohio lowered its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,707 shares of the company's stock after selling 2,102 shares during the quarter. Public Employees Retirement System of Ohio's holdings in DaVita were worth $2,798,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the stock. United Capital Financial Advisors LLC grew its position in DaVita by 2.6% during the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock worth $361,000 after buying an additional 62 shares in the last quarter. Freedom Investment Management Inc. lifted its stake in shares of DaVita by 3.6% in the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after acquiring an additional 62 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company's stock valued at $133,000 after acquiring an additional 68 shares during the last quarter. Coppell Advisory Solutions LLC lifted its stake in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after acquiring an additional 100 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of DaVita by 16.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 712 shares of the company's stock valued at $107,000 after acquiring an additional 101 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company's stock.
DaVita Trading Up 0.6%
DaVita stock traded up $0.84 during trading hours on Wednesday, reaching $136.83. 721,412 shares of the company's stock were exchanged, compared to its average volume of 821,654. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm's 50 day simple moving average is $143.15 and its 200 day simple moving average is $152.40. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60. The firm has a market capitalization of $10.33 billion, a PE ratio of 12.74, a PEG ratio of 1.07 and a beta of 1.11.
DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a return on equity of 115.48% and a net margin of 7.31%. The business's revenue was up 5.0% compared to the same quarter last year. During the same period last year, the business posted $2.26 EPS. Research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Finally, Truist Financial decreased their price target on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $164.50.
Read Our Latest Analysis on DaVita
DaVita Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Articles

Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.